Riccardo M Inciardi1, Andrea Rossi2, Giovanni Benfari1, Mariantonietta Cicoira1. 1. Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy. 2. Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy. andrea9rossi@gmail.com.
Abstract
PURPOSE OF REVIEW: Mitral regurgitation (MR) is one of the most frequent valvular heart diseases encountered in clinical practice. In contrast to primary MR, less is still known about the pathophysiology, diagnosis, and prognosis of secondary MR. The purpose of this report is to provide a review, upon the last knowledge reported in the literature, on the role and management of secondary MR in clinical practice. RECENT FINDINGS: Recent data highlight secondary MR not as a single pathological entity but as a wide spectrum of interconnected conditions which portend poor outcome. Although the role of secondary MR on clinical outcome is debated, recent available data suggest an independent association of MR with prognosis. Nevertheless, available treatment did not show a clear benefit after MR correction. Further studies are needed to better categorize and assess secondary MR beyond schematic classification. A management approach should be tailored upon each clinical context of presentation.
PURPOSE OF REVIEW: Mitral regurgitation (MR) is one of the most frequent valvular heart diseases encountered in clinical practice. In contrast to primary MR, less is still known about the pathophysiology, diagnosis, and prognosis of secondary MR. The purpose of this report is to provide a review, upon the last knowledge reported in the literature, on the role and management of secondary MR in clinical practice. RECENT FINDINGS: Recent data highlight secondary MR not as a single pathological entity but as a wide spectrum of interconnected conditions which portend poor outcome. Although the role of secondary MR on clinical outcome is debated, recent available data suggest an independent association of MR with prognosis. Nevertheless, available treatment did not show a clear benefit after MR correction. Further studies are needed to better categorize and assess secondary MR beyond schematic classification. A management approach should be tailored upon each clinical context of presentation.
Authors: Ronen Beeri; Chaim Yosefy; J Luis Guerrero; Francesca Nesta; Suzan Abedat; Miguel Chaput; Federica del Monte; Mark D Handschumacher; Robert Stroud; Suzanne Sullivan; Thea Pugatsch; Dan Gilon; Gus J Vlahakes; Francis G Spinale; Roger J Hajjar; Robert A Levine Journal: J Am Coll Cardiol Date: 2008-01-29 Impact factor: 24.094
Authors: Eddy Barasch; John S Gottdiener; Emily K Marino Larsen; Paulo H M Chaves; Anne B Newman; Teri A Manolio Journal: Am Heart J Date: 2006-01 Impact factor: 4.749
Authors: Paul A Grayburn; Blasé Carabello; Judy Hung; Linda D Gillam; David Liang; Michael J Mack; Patrick M McCarthy; D Craig Miller; Alfredo Trento; Robert J Siegel Journal: J Am Coll Cardiol Date: 2014-12-30 Impact factor: 24.094
Authors: Luis Nombela-Franco; Henrique Barbosa Ribeiro; Marina Urena; Ricardo Allende; Ignacio Amat-Santos; Robert DeLarochellière; Eric Dumont; Daniel Doyle; Hugo DeLarochellière; Jerôme Laflamme; Louis Laflamme; Eulogio García; Carlos Macaya; Pilar Jiménez-Quevedo; Mélanie Côté; Sebastien Bergeron; Jonathan Beaudoin; Philippe Pibarot; Josep Rodés-Cabau Journal: J Am Coll Cardiol Date: 2014-03-26 Impact factor: 24.094
Authors: Sylvestre Maréchaux; Dan Valentin Neicu; Sophie Braun; Marjorie Richardson; Pascal Delsart; Nadia Bouabdallaoui; Carlo Banfi; Corinne Gautier; Pierre Graux; Philippe Asseman; Philippe Pibarot; Thierry H Le Jemtel; Pierre Vladimir Ennezat Journal: J Card Fail Date: 2011-07-23 Impact factor: 5.712
Authors: Yong-Hwan Kim; Lawrence S C Czer; Harmik J Soukiasian; Michele De Robertis; Kathy E Magliato; Carlos Blanche; Sharo S Raissi; James Mirocha; Robert J Siegel; Robert M Kass; Alfredo Trento Journal: Ann Thorac Surg Date: 2005-06 Impact factor: 4.330
Authors: K Jane Grande-Allen; Allen G Borowski; Richard W Troughton; Penny L Houghtaling; Nicholas R Dipaola; Christine S Moravec; Ivan Vesely; Brian P Griffin Journal: J Am Coll Cardiol Date: 2005-01-04 Impact factor: 24.094